James Blanchard

TL;DR: Protection from superinfection was statistically significant in test monkeys; this protective state may serve as a 'gold-standard' for HIV-1 vaccine development, as a similar degree of protection against immunodeficiency virus infections in humans would be much desired.

TL;DR: Although HSV‐2 is the major cause of genital lesions, HSV-1 accounts for half of new cases in developed countries and is the most common cause of female genital herpes in developing countries.

TL;DR: The combination of suboptimal amounts of VRC01 and Rh-α4β7 delayed infection, altered antiviral immune responses and minimized CD4+ T cell loss is warranted and may lead to novel preventive and therapeutic strategies.

TL;DR: Early initiation of ART prevented virus-induced damage and did not impede mucosal or systemic immune functions in uninfected Chinese rhesus macaques.

TL;DR: It is demonstrated that the CD4-specific DARPin can rapidly and selectively bind its target cells in vivo, warranting further studies on possible clinical use of the DARPin technology.